Mitsubishi Tanabe Pharma America Announces Research Collaboration Between Mitsubishi Tanabe Pharma Corporation and Dewpoint Therapeutics to Advance Small Molecule Condensate Modulator for ALS
Press Releases
Mitsubishi Tanabe Pharma America  
December 17, 2024

Mitsubishi Tanabe Pharma America Announces Research Collaboration Between Mitsubishi Tanabe Pharma Corporation and Dewpoint Therapeutics to Advance Small Molecule Condensate Modulator for ALS

Collaboration aims to address underlying ALS pathology with innovative TDP-43 modulator technology

logo salamanca press

Salamanca Press

Local & Social